SCHEMBL25975997

SCHEMBL25975997

Cc1ccc2c(c1)NC(=O)CN(C)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.45
EPHX2 P34913 1/20 0.42
HTR5A P47898 2/20 0.41
BRD4 O60885 2/20 0.41
CREBBP Q92793 2/20 0.41
HSD17B10 Q99714 1/20 0.40
AKR1B1 P15121 1/20 0.39
PKM P14618 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CMA1 P23946 2/20 0.38
AHR P35869 2/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2061242 0.82 CA9 (0.58) BRD4CREBBPMEN1KMT2ACMA1
SCHEMBL25249364 0.82 CMA1 (0.60) BRD4CREBBPHSD17B10AKR1B1MEN1
SCHEMBL26228613 0.81 PARP1 (0.50) EPHX2BRD4CREBBPHSD17B10PKM
SCHEMBL26225761 0.80 HPGD (0.41) BRD4CREBBPHSD17B10MEN1KMT2A
SCHEMBL13090753 0.79 BRD4 (0.61) MMP12HTR5ABRD4CREBBPAKR1B1
SCHEMBL25223953 0.78 MAOB (0.35) BRD4CREBBPMEN1KMT2ACMA1
SCHEMBL2945674 0.77 BRD4 (0.62) EPHX2BRD4CREBBPKMT2AAHR
SCHEMBL2061201 0.77 TDP2 (0.47) AKR1B1MEN1KMT2AMAPTRAB9A
SCHEMBL278958 0.77 AHR (0.61) MMP12EPHX2HTR5ABRD4CREBBP
SCHEMBL1025832 0.75 CA9 (0.62) MMP12EPHX2HTR5ABRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed